https://mirapharmaceuticals.com/mira-pharmaceuticals-signs-binding-letter-of-intent-to-acquire-skny-pharmaceuticals-securing-a-5-million-capital-infusion-to-advance-weight-loss-and-smoking-cessation-drug-development/
MIRA Pharmaceuticals Signs Binding Letter of Intent to Acquire SKNY Pharmaceuticals, Securing a $5...
Mar 24, 2025 - Strategic acquisition expands MIRA's pipeline with SKNY-1, a next-generation oral therapeutic targeting the two leading causes of preventable death-obesity and...
letter of intent